Switzerland

M&A Report 

In addition to our M&A Yearbook we create a quarterly M&A reports that reflect the activities of the Swiss M&A market.

 

Our mid-year forecast that the M&A market would be extremely active during the second half of the year was confirmed. The third quarter of 2014 was impressive with transaction values in excess of USD 49.5 billion for a total of 87 transactions with Swiss involvement. Here it should be noted that the acquisition of the remaining 55% of Alliance Boots GmbH by Walgreen Company for USD 23.8 billion accounted for nearly half of the transaction volume yet represented the exercising of an option defined in 2012. Once this transaction has been completed, the corporation's new headquarters will be relocated to the USA. One remarkable aspect of activities during this quarter was the high level of activity seen in the pharmaceutical industry where four deals ranked in the Top 10. Major topics this quarter continued to be public acquisitions such as KUKA's acquisition of Swisslog, which is currently underway, and Danaher's acquisition of Nobel Biocare.

Top Swiss M&A transactions from July to September 2014

 

Announced date Target Stake Target country Bidder Bidder country Value (USDm)

Aug 2014

Alliance Boots GmbH

55

Switzerland

Walgreen Company

United States

 23'794

Aug 2014 InterMune Inc

100

United States Roche Holding AG Switzerland

 7'536

Jul 2014 WILD Flavors GmbH

100

Switzerland Archer Daniels Midland Company (ADM) United States

 3'129

Sep 2014 Nobel Biocare Holding AG

100

Switzerland Danaher Corporation United States

2'171

Jul 2014 BSI SA

100

Switzerland Banco BTG Pactual SA Brazil

1'681

Jul 2014 National Suisse

81

Switzerland Helvetia Holding AG Switzerland

1'605

Sep 2014 AAE Ahaus Alstaetter Eisenbahn AG

100

Switzerland VTG AG Germany

1'574

Jul 2014 Russell Stover Candies, Inc.

100

United States Lindt & Sprüngli AG Switzerland

1'400

Aug 2014 Venari Resources LLC

n/a

United States BlackRock Private Equity Partners; GIC Private Limited; Warburg Pincus LLC Switzerland

1'300

Jul 2014 Seragon Pharmaceuticals Inc.

100

United States Roche Holding AG (through Genentech Inc.) Switzerland

725

 

Number and value of deals per quarter

 


M&A Yearbook

rollup image ma yearbook
The "M&A Yearbook" provides an overview of the mergers and acquisitions in Switzerland over the last year well as an outlook for the coming year.